Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature
Zeinab Alnahas,1 Sujata Sarkar,1 Kevin T Trowell,1 Lisa Soltani,2 Sreekanth Vasireddy1 1Tucson Medical Center, Tucson, AZ, USA; 2El Rio Community Health Center, Tucson, AZ, USACorrespondence: Zeinab Alnahas, Tucson Medical Center, 5301 E Grant Road, Tucson, AZ, 85712, USA, Email Zeinab.Alnahas@tmcaz...
Saved in:
| Main Authors: | Alnahas Z, Sarkar S, Trowell KT, Soltani L, Vasireddy S |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Open Access Rheumatology: Research and Reviews |
| Subjects: | |
| Online Access: | https://www.dovepress.com/promise-of-jak-inhibition-in-the-management-of-vexas-case-report-with--peer-reviewed-fulltext-article-OARRR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Think VEXAS: a case report of Vexas syndrome
by: T. Najdi, et al.
Published: (2024-11-01) -
Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping reviewResearch in context
by: Fabio Efficace, et al.
Published: (2025-08-01) -
Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?
by: Sarah E. Packer, et al.
Published: (2025-08-01) -
The pathogenesis of amyloidosis in periodic disease: Some aspects
by: Z. T. Djndoyan
Published: (2014-07-01) -
Compound heterozygous variants in OTULIN are associated with fulminant atypical late‐onset ORAS
by: Julia Zinngrebe, et al.
Published: (2022-02-01)